JP2024508692A5 - - Google Patents
Info
- Publication number
- JP2024508692A5 JP2024508692A5 JP2023548257A JP2023548257A JP2024508692A5 JP 2024508692 A5 JP2024508692 A5 JP 2024508692A5 JP 2023548257 A JP2023548257 A JP 2023548257A JP 2023548257 A JP2023548257 A JP 2023548257A JP 2024508692 A5 JP2024508692 A5 JP 2024508692A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- inhibitor
- sting agonist
- sting
- egfr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148426P | 2021-02-11 | 2021-02-11 | |
| US63/148,426 | 2021-02-11 | ||
| PCT/US2022/015951 WO2022173932A1 (en) | 2021-02-11 | 2022-02-10 | Methods of treating cancers using sting agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508692A JP2024508692A (ja) | 2024-02-28 |
| JP2024508692A5 true JP2024508692A5 (enExample) | 2025-02-19 |
Family
ID=80787180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548257A Pending JP2024508692A (ja) | 2021-02-11 | 2022-02-10 | Ｓｔｉｎｇアゴニストを使用してがんを治療する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250009743A1 (enExample) |
| EP (1) | EP4291175A1 (enExample) |
| JP (1) | JP2024508692A (enExample) |
| CN (1) | CN117042767A (enExample) |
| AU (1) | AU2022218771A1 (enExample) |
| CA (1) | CA3210477A1 (enExample) |
| WO (1) | WO2022173932A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115969982A (zh) * | 2023-02-04 | 2023-04-18 | 哈尔滨医科大学 | Sting激动剂在制备用于抑制肿瘤血行转移的药物中的用途 |
| CN116676256A (zh) * | 2023-06-07 | 2023-09-01 | 浙江大学 | 细胞快速化学重编程技术 |
| CN118621012A (zh) * | 2024-06-07 | 2024-09-10 | 华中科技大学同济医学院附属同济医院 | Treg细胞作为HRD肿瘤的标记物及靶点的应用 |
| CN118649240A (zh) * | 2024-07-09 | 2024-09-17 | 哈尔滨医科大学附属肿瘤医院(哈尔滨医科大学附属第三医院、哈尔滨医科大学第三临床医学院、黑龙江省肿瘤医院) | 低氧抑制剂联合sting激动剂在制备用于治疗肿瘤药物中的应用 |
| CN118593534A (zh) * | 2024-07-17 | 2024-09-06 | 武汉科技大学 | 3'3'-cGAMP在制备增强MUC16 CAR-T对肿瘤细胞杀伤效果药物中的应用 |
| CN120860030B (zh) * | 2025-09-29 | 2026-01-27 | 四川大学华西医院 | Fgfr抑制剂在制备治疗颅咽管瘤的药物中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| AU687010B2 (en) | 1992-07-17 | 1998-02-19 | Dana-Farber Cancer Institute | Method of intracellular binding of target molecules |
| EP0745134A1 (en) | 1994-02-22 | 1996-12-04 | Danafarber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| AU2002355477B2 (en) | 2001-08-03 | 2008-09-25 | Medical Research Council | Method of identifying a consensus sequence for intracellular antibodies |
| US7004940B2 (en) | 2002-10-10 | 2006-02-28 | Ethicon, Inc. | Devices for performing thermal ablation having movable ultrasound transducers |
| WO2008020079A1 (en) | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| KR20200005662A (ko) * | 2017-05-18 | 2020-01-15 | 테사로, 인코포레이티드 | 암을 치료하기 위한 조합 요법 |
-
2022
- 2022-02-10 WO PCT/US2022/015951 patent/WO2022173932A1/en not_active Ceased
- 2022-02-10 CA CA3210477A patent/CA3210477A1/en active Pending
- 2022-02-10 US US18/274,823 patent/US20250009743A1/en active Pending
- 2022-02-10 JP JP2023548257A patent/JP2024508692A/ja active Pending
- 2022-02-10 AU AU2022218771A patent/AU2022218771A1/en active Pending
- 2022-02-10 EP EP22705336.0A patent/EP4291175A1/en active Pending
- 2022-02-10 CN CN202280023139.0A patent/CN117042767A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508692A5 (enExample) | ||
| Reilly et al. | Exploiting DNA repair defects in colorectal cancer | |
| Suraweera et al. | Epigenetic drugs in cancer therapy | |
| Shi et al. | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study | |
| Tang et al. | Erlotinib resistance in lung cancer: current progress and future perspectives | |
| Fakih et al. | A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer | |
| JP2017516784A5 (enExample) | ||
| Bhalla et al. | PARP-inhibitors in BRCA-associated pancreatic cancer | |
| ES2913097T3 (es) | Uso de derivados de quinolina para el tratamiento del cáncer de esófago y método de tratamiento, composición farmacéutica y equipo de los mismos | |
| JP2003533485A5 (enExample) | ||
| CN111643503A (zh) | 用于治疗非小细胞肺癌的喹啉衍生物 | |
| CA3095709A1 (en) | Novel combinations of a tubulin polymerization inhibitor and a poly (adp-ribose) polymerase (parp) inhibitor for use in the treatment of cancer | |
| CA2902144A1 (en) | Methods and compositions for treating cancers having acquired resistance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate | |
| Li et al. | Exploring hypoxic biology to improve radiotherapy outcomes | |
| JP2024513575A5 (enExample) | ||
| JP2024510666A5 (enExample) | ||
| Lee et al. | Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer | |
| Epp-Ducharme et al. | Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro | |
| ES2389809T3 (es) | Terapias anticancerosas | |
| Kurniali et al. | Role of calcium/magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients | |
| CN112638385B (zh) | 用于治疗脑肿瘤的喹啉衍生物 | |
| JP2024538719A5 (enExample) | ||
| CN111643502A (zh) | 喹啉衍生物联合化疗药物用于治疗非小细胞肺癌 | |
| US20210283149A1 (en) | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
| CN114173785A (zh) | 用于治疗非小细胞肺癌的氨基吡啶衍生物 |